Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
References 1.Alfaris N., Waldrop S., Johnson V., Boaventura B., Kendrick K., Stanford F.C
Despite 5-fluorouracil (5-FU) being a primary treatment for CRC, resistance to 5-FU often leads to treatment failure and relapses
Among those who experienced side effects, 96% were mild to moderate
A label was updated with new safety warnings about hypersensitivity reactions and recommends infusion dosage modifications based on these infusion-related reactions
)
J., Hendesi, H., Villani, D
Market disrupters The GLP-1 cash market also happens to be transparent, which vastly differs from the opaque, convoluted price negotiations between manufacturers and pharmacy benefit managers for most prescription drugs
US$ 22.22
US$ 24.40
US$ 23.81
